News
7don MSN
Novo’s shares have plunged since hitting a record-high in June last year as competition, particularly from Eli Lilly, makes ...
The lawsuit accuses drug manufacturer Novo Nordisk of failing to warn patients of the possible association between the popular drug and an eye condition called NAION.
A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
We expected miracles; what we got was a legal minefield. As GLP-1 drugs like Ozempic reshape bodies and bottom lines, a ...
Among all the weight loss drugs, Ozempic has ... business and market development information that may be of help with your own research. Ramping up production despite lawsuits.
Ozempic's double-sided coin: Amid skyrocketing popularity of GLP-1 drugs, a burgeoning lawsuit looms
Ozempic was originally approved by the Food and Drug Administration (FDA) to treat people with Type 2 diabetes, who risk ...
Nationwide, more than a dozen lawsuits have been filed alleging vision loss after taking Ozempic or Wegovy, said Jason Goldstein, senior litigation counsel with Parker Waichman LLP, who represents ...
Todd Engel, 62, was prescribed Ozempic in 2023 to manage his Type 2 diabetes. The lawsuit said about four months later, Engel was diagnosed with nonarteritic anterior ischemic optic neuropathy ...
More than a dozen lawsuits have been filed on behalf of weight-loss drug users who claim that popular weight-loss medications such as Ozempic have caused a loss of vision. Patients from New York and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results